These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6662119)

  • 1. Hypertension in pregnancy: evaluation of two beta blockers atenolol and labetalol.
    Lardoux H; Gerard J; Blazquez G; Chouty F; Flouvat B
    Eur Heart J; 1983 Nov; 4 Suppl G():35-40. PubMed ID: 6662119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
    Gérard J; Blazquez G; Lardoux H; Beauséjour B; Faurie C; Rousset D; Flouvat B
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(8):891-900. PubMed ID: 6672083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which beta-blocker in pregnancy-induced hypertension?
    Lardoux H; Gerard J; Blazquez G; Flouvat B
    Lancet; 1983 Nov; 2(8360):1194. PubMed ID: 6139547
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of arterial hypertension in the pregnant woman with labetalol. A propos of 24 cases].
    Dubois D; Petitcolas J; Temperville B; Klepper A; Leboullenger P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):691-700. PubMed ID: 6520355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evaluation of labetalol in the treatment of hypertension complicating pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):127S-131S. PubMed ID: 7093096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of atenolol, labetalol and propranolol on the peripheral circulation in hypertensive patients without obstructive vascular disease.
    van der Veur E; ten Berge BS; Wouda AA; Wesseling H
    Eur J Clin Pharmacol; 1985; 28(2):131-4. PubMed ID: 3987794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertension.
    Nilsson OR; Karlberg BE; Henningsen NC; Thulin T
    Acta Med Scand Suppl; 1982; 665():117-9. PubMed ID: 6760679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of labetalol in the treatment of severe hypertension during pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):211S-215S. PubMed ID: 526403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind trial comparing labetalol with atenolol in the treatment of systemic hypertension with angina pectoris.
    Jee LD; Opie LH
    Am J Cardiol; 1985 Sep; 56(8):551-4. PubMed ID: 3929584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Labetalol for the treatment of hypertension in pregnancy. Pharmacokinetics and effects on the uteroplacental blood flow.
    Nylund L; Lunell NO; Lewander R; Sarby B; Thornström S
    Acta Obstet Gynecol Scand Suppl; 1984; 118():71-3. PubMed ID: 6587732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
    Lamming GD; Broughton Pipkin F; Symonds EM
    Clin Exp Hypertens (1978); 1980; 2(5):865-95. PubMed ID: 7428566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma.
    Jackson SH; Beevers DG
    Br J Clin Pharmacol; 1983 May; 15(5):553-6. PubMed ID: 6860529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind crossover comparison of pindolol, metoprolol, atenolol and labetalol in mild to moderate hypertension.
    McNeil JJ; Louis WJ
    Br J Clin Pharmacol; 1979; 8(Suppl 2):163S-166S. PubMed ID: 43164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocker subtypes and risk of low birth weight in newborns.
    Duan L; Ng A; Chen W; Spencer HT; Lee MS
    J Clin Hypertens (Greenwich); 2018 Nov; 20(11):1603-1609. PubMed ID: 30267456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined alpha/beta-blockade versus beta 1-selective blockade in essential hypertension in black and white patients.
    Townsend RR; DiPette DJ; Goodman R; Blumfield D; Cronin R; Gradman A; Katz LA; McCarthy EP; Sopko G
    Clin Pharmacol Ther; 1990 Dec; 48(6):665-75. PubMed ID: 2249378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis.
    Saotome T; Minoura S; Terashi K; Sato T; Echizen H; Ishizaki T
    J Clin Pharmacol; 1993 Oct; 33(10):979-88. PubMed ID: 8227470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy.
    Lunell NO; Hjemdahl P; Fredholm BB; Nisell H; Persson B; Wager J
    Br J Clin Pharmacol; 1981 Sep; 12(3):345-8. PubMed ID: 7295464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemodynamic effects of atenolol, labetalol, pindolol and captopril: a comparison in hypertensive patients with special reference to changes in limb blood flow, heart rate and left ventricular function.
    Br J Clin Pharmacol; ; . PubMed ID: 2887190
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.